Patterson Companies Inc
F:PD2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its 3-Year Average (13.5), the stock would be worth €18.57 (32% downside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 20 | €27.4 |
0%
|
| 3-Year Average | 13.5 | €18.57 |
-32%
|
| 5-Year Average | 13.9 | €19.13 |
-30%
|
| Industry Average | 27.6 | €37.86 |
+38%
|
| Country Average | 22.9 | €31.38 |
+15%
|
Forward P/E
Today’s price vs future net income
| Today's Market Cap | Net Income | Forward P/E | ||
|---|---|---|---|---|
|
€2.8B
|
/ |
Jan 2025
$138.8m
|
= |
|
|
€2.8B
|
/ |
Apr 2025
$192.5m
|
= |
|
|
€2.8B
|
/ |
Apr 2026
$210.9m
|
= |
|
|
€2.8B
|
/ |
Apr 2027
$227.9m
|
= |
|
Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
|
Patterson Companies Inc
F:PD2
|
2.8B EUR | 20 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
101.9B USD | 23.5 | |
| US |
|
Cencora Inc
NYSE:COR
|
60.3B USD | 37.2 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
60.4B USD | 37.2 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
47.8B USD | 28.7 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
31.9B AUD | 34.6 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
61.9B CNY | 10.8 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
60B CNY | 21.2 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD | 22.5 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
57.7B HKD | 7.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 15.3 |
| Median | 22.9 |
| 70th Percentile | 33.2 |
| Max | 1 826 183.3 |
Other Multiples
Patterson Companies Inc
Glance View
Patterson Companies Inc., a prominent player in the healthcare distribution sector, has carved its niche by focusing on two essential markets: dental and animal health. Established in the late 19th century, Patterson began as a humble supplier of dental products, and over the decades, it expanded its portfolio to meet the growing demands of an ever-evolving healthcare landscape. This expansion is exemplified in its strategic shift towards animal health, a sector that has burgeoned with rising global pet ownership and increased attention to veterinary care. Through its extensive network, Patterson supplies everything from dental chairs and compressors to veterinarians' pharmaceuticals and surgical equipment, ensuring practitioners are well-equipped to meet their patients' needs. Much of Patterson's success can be attributed to its diversified distribution model and its focus on building strong relationships with manufacturers and healthcare providers. Operating in the highly competitive distribution industry, Patterson generates revenue by acting as a bridge between manufacturers and a wide-reaching customer base. This involves not just logistical expertise to get products where they need to be, but also offering value-added services such as training, integrated technology solutions, and business consulting to its clients. By embedding itself deeper into its clients' operational ecosystems, Patterson ensures customer loyalty and positions itself as more than just a supplier, but a crucial partner in healthcare outcomes.